Rotate to portrait

Vizual Stocks works best vertically on mobile.

VizualStocks API
PUBLIC DATA DEFINITIONS

Halozyme Therapeutics KPI & segment coverage

Operating KPI and segment definitions available for Halozyme Therapeutics (HALO) through the VizualStocks API.

HALO2 metric seriesCatalog checked 2026-10-28
Metric catalog API reference Open in the interactive demo

Active metrics 2

SEGMENT

Product Sales Net

Halozyme net revenue from physical products, including bulk rHuPH20 enzyme supplied to ENHANZE partners and proprietary or partnered drug-delivery products. It is separate from partner royalties and collaboration fees.

productSalesNet
Frequency
quarterly / annual
Reported history
Q4'24 — Q2'26
History endpoint
SEGMENT

Royalty Revenue

Halozyme royalty revenue from partners marketed therapies and drug-delivery products, led by ENHANZE-enabled subcutaneous medicines. This excludes upfront licensing and milestone fees and physical product sales.

royaltyRevenue
Frequency
quarterly / annual
Reported history
Q4'24 — Q2'26
History endpoint